TrialThe Journal of allergy and clinical immunology2020

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.

Florence Roufosse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.